Population analysis of ethnicity and first-phase insulin release

Diabetes Research and Clinical Practice

Volumn 89, Issue 3, 2010, Pages 243-249

  Xie, Lanyi ^a   Hoffman, Robert P ^b   Veng Pedersen, Peter ^a  

^a UNIVERSITY OF IOWA   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Beta cell; Ethnicity; First phase insulin; Insulin modeling; Intravenous glucose tolerance test; Pharmacodynamics; Pharmacokinetics

Indexed keywords

BIPHASIC INSULIN; GLUCOSE;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CONTROLLED STUDY; EARLY DIAGNOSIS; ETHNICITY; FEMALE; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; KINETICS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; STATISTICAL MODEL;

EID: 77955412770     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.04.025     Document Type: Article

References (38)

1. Wang Y., Beydoun M.A. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007, 29:6-28.
2. Goran M.I., Bergman R.N., Cruz M.L., Watanabe R. Insulin resistance and associated compensatory responses in african-american and Hispanic children. Diabetes Care 2002, 25:2184-2190.
3. Uwaifo G.I., Nguyen T.T., Keil M.F., Russell D.L., Nicholson J.C., Bonat S.H., et al. Differences in insulin secretion and sensitivity of Caucasian and African American prepubertal children. J Pediatr 2002, 140:673-680.
4. Arslanian S. Insulin secretion and sensitivity in healthy African-American vs American white children. Clin Pediatr (Phila) 1998, 37:81-88.
5. Arslanian S., Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity of healthy black versus white adolescents. J Pediatr 1996, 129:440-443.
6. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993, 329:1988-1992.
7. Warram J.H., Martin B.C., Krolewski A.S., Soeldner J.S., Kahn C.R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Int Med 1990, 113:909-915.
8. Duck M.M., Hoffman R.P. Impaired endothelial function in healthy African-American adolescents compared with Caucasians. J Pediatr 2007, 150:400-406.
9. Preeyasombat C., Bacchetti P., Lazar A.A., Lustig R.H. Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children. J Pediatr 2005, 146:474-481.
10. Arslanian S.A., Saad R., Lewy V., Danadian K., Janosky J. Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002, 51:3014-3019.
11. Xie L., Hoffman R.P., Veng-Pedersen P. Noncompartmental pharmacokinetics analysis of glucose-stimulated insulin response in African-American and Caucasian youths. Biopharm Drug Dispos 2009, 30:117-125.
12. Cerasi E., Luft R. The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol (Copenh) 1967, 55:278-304.
13. Davies M.J., Rayman G., Grenfell A., Gray I.P., Day J.L., Hales C.N. Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diab Med 1994, 11:432-436.
14. Bergman R.N., Phillips L.S., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981, 68:1456-1467.
15. Grodsky G.M. A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest 1972, 51:2047-2059.
16. Gupta N., Hoffman R.P., Veng-Pedersen P. Pharmacokinetic/pharmacodynamic differentiation of pancreatic responsiveness in obese and lean children. Biopharm Drug Dispos 2005, 26:287-294.
17. Monolix, ;2008. http://software.monolix.org/.
18. Panhard X., Samson A. Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects. Biostatistics 2009, 10:121-135.
19. Kuhn E., Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. Ann Stat 2005, 49:1020-1038.
20. Kuhn E., Lavielle M. Coupling a stochastic approximation version of EM with an MCMC procedure. ESAIM: P&S 2004, 8:115-131.
21. Delyon B., Lavielle M., Moulines E. Convergence of a stochastic approximation version of the EM algorithm. Ann Stat 1999, 27:94-128.
22. Halban P.A. Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell. Diabetologia 1991, 34:767-778.
23. Bratanova-Tochkova T.K., Cheng H., Daniel S., Gunawardana S., Liu Y.J., Mulvaney-Musa J., et al. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 2002, 51(Suppl. 1):S83-90.
24. Daniel S, Noda M., Straub S.G., Sharp G.W. Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes 1999, 48:1686-1690.
25. O'Connor M.D., Landahl H., Grodsky G.M. Comparison of storage- and signal-limited models of pancreatic insulin secretion. Am J Physiol 1980, 238:R378-389.
26. Grodsky G.M., Curry D., Landahl H., Benet L. Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system. Acta Diabetol Lat 1969, 6(Suppl. 1):554-578.
27. Melloul D., Marshak S., Cerasi E. Regulation of insulin gene transcription. Diabetologia 2002, 45:309-326.
28. Jarrett R.J., Keen H., Track N. Glucose and RNA synthesis in mammalian islets of Langerhans. Nature 1967, 213:634-635.
29. Permutt M.A., Kipnis D.M. Insulin biosynthesis. I. On the mechanism of glucose stimulation. J Biol Chem 1972, 247:1194-1199.
30. Dean P.M. Ultrastructural morphometry of the pancreatic cell. Diabetologia 1973, 9:115-119.
31. Pedersen P.V. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm 1977, 5:513-531.
32. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Control 1974, 19:716-723.
33. Field J.B. Extraction of insulin by liver. Annu Rev Med 1973, 24:309-314.
34. Home P.D., Massi-Benedetti M., Shepherd G.A., Hanning I., Alberti K.G., Owens D.R. A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique. Diabetologia 1982, 22:41-45.
35. Sherwin R.S., Kramer K.J., Tobin J.D., Insel P.A., Liljenquist J.E., Berman M., et al. A model of the kinetics of insulin in man. J Clin Invest 1974, 53:1481-1492.
36. Volund A., Polonsky K.S., Bergman R.N. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes 1987, 36:1195-1202.
37. Juhl C., Grofte T., Butler P.C., Veldhuis J.D., Schmitz O., Porksen N. Effects of fasting on physiologically pulsatile insulin release in healthy humans. Diabetes 2002, 51(Suppl. 1):S255-257.
38. Ku C.Y., Gower B.A., Hunter G.R., Goran M.I. Racial differences in insulin secretion and sensitivity in prepubertal children: role of physical fitness and physical activity. Obes Res 2000, 8:506-515.